• Working in the present,
    thinking the future

  • Health, our greatest asset value

  • Pharmacovigilance

  • Patient Centricity

We provide drugs with a high added value for health care and treatments for high complexity diseases, for both overall patients and the medical and scientific community

Our products

are mainly addressed to be used in hematologic, oncologic, urologic and neurologic pathologies as well as rare diseases

Products

Hematology
Oncology
Neurology
Urology
Rare diseases

News

New Product Lunch IMPILO®bexarotene

08/07/2024

Bioprofarma Bagó replaces TARGRETIN® with IMPILO®bexarotene.

Read note

(Español) Nuevo lanzamiento HUTUS® enzalutamida

03/06/2024

(Español) Nos complace presentarles nuestro nuevo producto HUTUS® enzalutamida para cáncer de próstata

Read note

XXVI Argentine and International Congress of Clinical Oncology organized by the AAOC

16/11/2023

November 8-10, the XXVI Argentine and International Congress of Clinical Oncology 2023 was held at La Rural, in the City of Buenos Aires, and Bioprofarma Bago was there.

Read note

Bioprofarma Bagó worldwide